Shu Ching Lin
Director/Board Member bij UNITED BIOPHARMA INC
Profiel
Shu Ching Lin is currently a Director at United BioPharma, Inc. and Shanghai Shen Lian Biomedical Corp.
She was formerly a Director at UBI Pharma Inc. She received her undergraduate and doctorate degrees from National Taiwan University.
Actieve functies van Shu Ching Lin
| Bedrijven | Functie | Begin |
|---|---|---|
| UNITED BIOPHARMA INC | Director/Board Member | 30-09-2013 |
| SHANGHAI SHEN LIAN BIOMEDICAL CORPORATION | Director/Board Member | - |
Eerdere bekende functies van Shu Ching Lin
| Bedrijven | Functie | Einde |
|---|---|---|
| UBI PHARMA INC. | Director/Board Member | - |
Opleiding van Shu Ching Lin
| National Taiwan University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| UBI PHARMA INC. | Health Technology |
| SHANGHAI SHEN LIAN BIOMEDICAL CORPORATION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
United BioPharma, Inc.
 United BioPharma, Inc. Pharmaceuticals: MajorHealth Technology United BioPharma, Inc. engages in the development, manufacture, and sale of monoclonal antibody drug. The company's business activities include the manufacture and sale of western drugs. Its products include trastumab, adalimumab, bevacizumab, rituximab, and omalizumab. The company was founded by Chang Yi Wang on September 30, 2013 and is headquartered in Hsinchu, Taiwan. | Health Technology |
